Vesamicol hydrochloride

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591421

CAS#: 23965-53-9

Description: Vesamicol hydrochloride is a biochemical.


Chemical Structure

img
Vesamicol hydrochloride
CAS# 23965-53-9

Theoretical Analysis

MedKoo Cat#: 591421
Name: Vesamicol hydrochloride
CAS#: 23965-53-9
Chemical Formula: C17H26CLNO
Exact Mass: 295.17
Molecular Weight: 295.850
Elemental Analysis: C, 69.02; H, 8.86; Cl, 11.98; N, 4.73; O, 5.41

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Vesamicol hydrochloride; AH 5183 hydrochloride; AH-5183 hydrochloride; AH5183 hydrochloride

IUPAC/Chemical Name: Cyclohexanol, 2-(4-phenylpiperidino)-, hydrochloride

InChi Key: XJNUHVMJVWOYCW-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H25NO.ClH/c19-17-9-5-4-8-16(17)18-12-10-15(11-13-18)14-6-2-1-3-7-14;/h1-3,6-7,15-17,19H,4-5,8-13H2;1H

SMILES Code: OC1C(N2CCC(C3=CC=CC=C3)CC2)CCCC1.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 295.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ogawa K, Masuda R, Mizuno Y, Makino A, Kozaka T, Kitamura Y, Kiyono Y, Shiba K, Odani A. Development of a novel radiobromine-labeled sigma-1 receptor imaging probe. Nucl Med Biol. 2018 Apr 6;61:28-35. doi: 10.1016/j.nucmedbio.2018.03.005. [Epub ahead of print] PubMed PMID: 29704822.

2: Lindemann M, Deuther-Conrad W, Moldovan R, Sekhar KVGC, Brust P, Wenzel B. Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter? Bioorg Med Chem. 2017 Oct 1;25(19):5107-5113. doi: 10.1016/j.bmc.2017.03.028. Epub 2017 Mar 18. PubMed PMID: 28347632.

3: Sharma A, Agarwal J, Peddinti RK. Direct access to the optically active VAChT inhibitor vesamicol and its analogues via the asymmetric aminolysis of meso-epoxides with secondary aliphatic amines. Org Biomol Chem. 2017 Feb 22;15(8):1913-1920. doi: 10.1039/c6ob02479c. PubMed PMID: 28169381.

4: Gaydukov AE, Bogacheva PO, Balezina OP. Calcitonin gene-related peptide increases acetylcholine quantal size in neuromuscular junctions of mice. Neurosci Lett. 2016 Aug 15;628:17-23. doi: 10.1016/j.neulet.2016.06.014. Epub 2016 Jun 7. PubMed PMID: 27288020.

5: Jin H, Zhang X, Yue X, Liu H, Li J, Yang H, Flores H, Su Y, Parsons SM, Perlmutter JS, Tu Z. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates. Nucl Med Biol. 2016 Feb;43(2):131-9. doi: 10.1016/j.nucmedbio.2015.11.003. Epub 2015 Nov 7. PubMed PMID: 26872437; PubMed Central PMCID: PMC4753027.

6: Kitamura Y, Kozaka T, Miwa D, Uno I, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter. Ann Nucl Med. 2016 Feb;30(2):122-9. doi: 10.1007/s12149-015-1039-6. Epub 2015 Nov 25. PubMed PMID: 26608176.

7: Shen B, James ML, Andrews L, Lau C, Chen S, Palner M, Miao Z, Arksey NC, Shuhendler AJ, Scatliffe S, Kaneshige K, Parsons SM, McCurdy CR, Salehi A, Gambhir SS, Chin FT. Further validation to support clinical translation of [(18)F]FTC-146 for imaging sigma-1 receptors. EJNMMI Res. 2015 Dec;5(1):49. doi: 10.1186/s13550-015-0122-2. Epub 2015 Sep 17. PubMed PMID: 26384292; PubMed Central PMCID: PMC4573970.

8: Nassenstein C, Wiegand S, Lips KS, Li G, Klein J, Kummer W. Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters. Int Immunopharmacol. 2015 Nov;29(1):173-80. doi: 10.1016/j.intimp.2015.08.007. Epub 2015 Aug 13. PubMed PMID: 26278668.

9: Tu Z, Zhang X, Jin H, Yue X, Padakanti PK, Yu L, Liu H, Flores HP, Kaneshige K, Parsons SM, Perlmutter JS. Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter. Bioorg Med Chem. 2015 Aug 1;23(15):4699-709. doi: 10.1016/j.bmc.2015.05.058. Epub 2015 Jun 5. PubMed PMID: 26138195; PubMed Central PMCID: PMC4524497.

10: Barthel C, Sorger D, Deuther-Conrad W, Scheunemann M, Schweiger S, Jäckel P, Roghani A, Steinbach J, Schüürmann G, Sabri O, Brust P, Wenzel B. New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure. Eur J Med Chem. 2015 Jul 15;100:50-67. doi: 10.1016/j.ejmech.2015.05.033. Epub 2015 May 22. PubMed PMID: 26071858.

11: Zou Q, Leung SW, Vanhoutte PM. Transient Receptor Potential Channel Opening Releases Endogenous Acetylcholine, which Contributes to Endothelium-Dependent Relaxation Induced by Mild Hypothermia in Spontaneously Hypertensive Rat but Not Wistar-Kyoto Rat Arteries. J Pharmacol Exp Ther. 2015 Aug;354(2):121-30. doi: 10.1124/jpet.115.223693. Epub 2015 Jun 9. PubMed PMID: 26060231.

12: Bergman S, Estrada S, Hall H, Rahman R, Blomgren A, Larhed M, Svedberg M, Thibblin A, Wångsell F, Antoni G. Synthesis and labeling of a piperazine-based library of ¹¹C-labeled ligands for imaging of the vesicular acetylcholine transporter. J Labelled Comp Radiopharm. 2014 Jun 30;57(8):525-32. doi: 10.1002/jlcr.3208. Epub 2014 Jul 3. PubMed PMID: 24991704.

13: Azim MA, Kozaka T, Uno I, Miwa D, Kitamura Y, Ogawa K, Makino A, Kiyono Y, Shiba K. The potential of o-bromo-trans-decalinvesamicol as a new PET ligand for vesicular acetylcholine transporter imaging. Synapse. 2014 Oct;68(10):445-53. doi: 10.1002/syn.21756. Epub 2014 Jul 4. PubMed PMID: 24953217.

14: Bader S, Klein J, Diener M. Choline acetyltransferase and organic cation transporters are responsible for synthesis and propionate-induced release of acetylcholine in colon epithelium. Eur J Pharmacol. 2014 Jun 15;733:23-33. doi: 10.1016/j.ejphar.2014.03.036. Epub 2014 Mar 31. PubMed PMID: 24698650.

15: Nishiyama S, Ohba H, Kobashi T, Nakamasu Y, Nakao H, Ogata T, Kitashoji T, Tsukada H. Development of novel PET probe [¹¹C](R,R)HAPT and its stereoisomer [¹¹C](S,S)HAPT for vesicular acetylcholine transporter imaging: a PET study in conscious monkey. Synapse. 2014 Jul;68(7):283-92. doi: 10.1002/syn.21743. Epub 2014 Apr 12. PubMed PMID: 24687885.

16: Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med. 2014 Mar;55(3):396-404. doi: 10.2967/jnumed.113.124792. Epub 2014 Jan 30. PubMed PMID: 24481024.

17: Kilbourn MR. PET radioligands for the vesicular transporters for monoamines and acetylcholine. J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):167-71. doi: 10.1002/jlcr.2998. Review. PubMed PMID: 24285322.

18: Rodrigues HA, Fonseca Mde C, Camargo WL, Lima PM, Martinelli PM, Naves LA, Prado VF, Prado MA, Guatimosim C. Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction. PLoS One. 2013 Nov 8;8(11):e78342. doi: 10.1371/journal.pone.0078342. eCollection 2013. PubMed PMID: 24260111; PubMed Central PMCID: PMC3832638.

19: Kozaka T, Uno I, Kitamura Y, Miwa D, Anwar-Ul Azim M, Ogawa K, Shiba K. Regional brain imaging of vesicular acetylcholine transporter using o-[125 I]iodo-trans-decalinvesamicol as a new potential imaging probe. Synapse. 2014 Mar;68(3):107-13. doi: 10.1002/syn.21720. Epub 2013 Nov 15. PubMed PMID: 24174343.

20: Ogawa K, Kanbara H, Kiyono Y, Kitamura Y, Kiwada T, Kozaka T, Kitamura M, Mori T, Shiba K, Odani A. Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging. Nucl Med Biol. 2013 May;40(4):445-50. doi: 10.1016/j.nucmedbio.2013.02.008. Epub 2013 Mar 23. PubMed PMID: 23528561.